Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia.
Catani
L
L
Zini
R
R
Sollazzo
D
D
Ottaviani
E
E
Vannucchi
A M
AM
Ferrari
S
S
Baccarani
M
M
Vianelli
N
N
Lemoli
R M
RM
Manfredini
R
R
D000328:Adult; D000368:Aged; D018952:Antigens, CD34 / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D013234:Stem Cells / Q000378:metabolism*; D013920:Thrombocythemia, Essential / Q000235:genetics* / Q000378:metabolism / Q000473:pathology
D018952:Antigens, CD34; D014408:Biomarkers, Tumor; C507924:JAK2 protein, human; D053614:Janus Kinase 2